According to the announcement from the company, the award recognizes the distinctive expertise of Thermo Fisher Scientific, its insight into individual customer requirements and its technological innovation and advanced solutions for cell-based screening and analysis. Frost & Sullivan has identified Thermo Fisher Scientific, with its range of Cellomics HCS products, as excellent in all areas of market leadership, demonstrating the ability to monitor market changes and implement superior market strategies to meet rapidly changing industry demands.

Commenting on the award, Monette Greenway, president, Integrative Technologies Division, Thermo Fisher Scientific, said “This accolade reflects our ability to react to a rapidly changing market. As HCS has increased in usage and discovery scientists have been demanding more advanced HCS platforms, our strategy has been to develop products that will enable us to provide our customers with a fully integrated, high-value HCS solution. In addition to our Cellomics range of advanced imaging technologies and software, we have a fully integrated offering which includes high-quality fluorescent reagents, engineered cells, data management, automation, informatics and bioinformatics tools.”